News

Filter

Japanese approvals for Eylea, Tresiba, Seebri and Aimix

01-10-2012

There was a flurry of announcements from Japan's Ministry of Health, Labor and Welfare (MHLW) on Friday,…

AimixAsia-PacificBayerCardio-vascularDainippon Sumitomo PharmaDiabetesEyleaNovartisNovo NordiskOphthalmicsPharmaceuticalRegeneronRegulationRespiratory and PulmonarySeebri BreezhalerShionogiTresibaVectura

Silence Thera receives takeover approach from unnamed drug firm

07-09-2010

UK-based drug developer Silence Therapeutics (AIM: SLN) saw its share price skyrocket 76% to 12.75 pence…

AstraZenecaBiotechnologyDainippon Sumitomo PharmaMergers & AcquisitionsNovartisPharmaceuticalSilence Therapeutics

COMPANY SPOTLIGHT

Menarini

Back to top